In addition to increased p53 expression, Abdulamir et al reported more frequent expression of BCL-2, c-myc, and Rb in bladder biopsy specimens in Sh-associated bladder cancer in Jordan and Syria [179]. This evidence concerns the gene BCL2 and urinary bladder cancer.